Episomal vectors to monitor and induce somatic hypermutation in human Burkitt-Lymphoma cell lines

被引:11
|
作者
Rückerl, F [1 ]
Busse, B [1 ]
Bachl, J [1 ]
机构
[1] GSF, Natl Res Ctr Environm & Hlth, Inst Clin Mol Biol & Tumor Genet, D-81377 Munich, Germany
关键词
somatic hypermutation; activation induced cytidine deaminase; Burkitt's lymphoma; episomal vectors; GFP reversion assay;
D O I
10.1016/j.molimm.2005.09.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Somatic hypermutation (SHM) occurs at a specific B-cell differentiation stage. during the germinal centre reaction, and provides a means to diversify and shape the antibody repertoire of the adaptive immune system. Burkitt-Lymphoma (BL) is a germinal centre derived B-cell malignancy. Presumably deregulation of the somatic hypermutation- and/or class switch recombination process causes a translocation between the myc-locus and one of the Ig-loci, which is characteristic for BL. We show here that we developed an episomal-based vector system to monitor and induce AID-dependent somatic hypel-mutation in human cell lines. Exemplarily, we utilized this system to investigate the hypermutation status of various BL cell lines. Analysis of the influence of Ig-specific cis-regulatory, elements for the mutability of a green fluorescent protein (GFP) reporter transgene revealed, that the presence of la-enhancers is required for an efficient targeting of a constitutively transcribed GFP transgene. In contrast, a transcriptional inducible GFP transgene was hypermutated by overexpression of activation-induced cytidine deaminase (AID), even in the absence of Ig-specific sequences. This observation verifies that overexpression of AID in non hypermutatingg BL cell lines as well as the expression of endogenous AID in the hypermutating BL cell line Raji can overcome the target restriction of AID. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1645 / 1652
页数:8
相关论文
共 50 条
  • [31] ESTABLISHMENT AND CHARACTERIZATION OF A NEW HUMAN BURKITT-LYMPHOMA CELL-LINE (WSU-BL)
    MOHAMED, AN
    MOHAMMAD, RM
    KOOP, BF
    ALKATIB, A
    CANCER, 1989, 64 (05) : 1041 - 1048
  • [32] REVERSIBLE GL ARREST OF A HUMAN BURKITT-LYMPHOMA CELL-LINE (RAJI) INDUCED BY TUNICAMYCIN
    NISHIKAWA, Y
    YAMAMOTO, Y
    KAJI, K
    MITSUI, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1980, 97 (04) : 1296 - 1303
  • [33] CELL-DENSITY CONTROL OF PROLIFERATION IN A BURKITT-LYMPHOMA CELL-LINE
    SILVOTTI, L
    PIEDIMONTE, G
    PETRONINI, PG
    FAVILLA, R
    BORGHETTI, AF
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 547 - 547
  • [34] ONCOGENE EXPRESSION IN ISOGENIC, EBV-POSITIVE AND EBF-NEGATIVE BURKITT-LYMPHOMA CELL-LINES
    GLAZER, PM
    SUMMERS, WC
    INTERVIROLOGY, 1985, 23 (02) : 82 - 89
  • [35] PERSISTENT HERPES-SIMPLEX VIRUS-INFECTIONS ESTABLISHED IN 2 BURKITT-LYMPHOMA DERIVED CELL LINES
    ROBEY, WG
    GRAHAM, BJ
    HARRIS, CL
    MADDEN, MJ
    PEARSON, GR
    VANDEWOUDE, GF
    JOURNAL OF GENERAL VIROLOGY, 1976, 32 (JUL): : 51 - 62
  • [36] ROLE OF SPECIFIC TRANSLOCATIONS IN THE GENESIS OF RODENT PLASMACYTOMA AND HUMAN BURKITT-LYMPHOMA
    KLEIN, G
    BIOLOGY OF THE CELL, 1982, 45 : 56 - 56
  • [37] Epstein-Barr virus and the somatic hypermutation of immunoglobulin genes in Burkitt's lymphoma cells
    Harris, RS
    Croom-Carter, DSG
    Rickinson, AB
    Neuberger, MS
    JOURNAL OF VIROLOGY, 2001, 75 (21) : 10488 - 10492
  • [38] AN ENHANCER FACTOR DEFECT IN A MUTANT BURKITT-LYMPHOMA CELL-LINE
    KOCH, W
    CANDEIAS, S
    GUARDIOLA, J
    ACCOLLA, R
    BENOIST, C
    MATHIS, D
    JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (06): : 1781 - 1790
  • [39] Somatic hypermutation in human B cell subsets
    Longo, NS
    Lipsky, PE
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2001, 23 (04): : 367 - 385
  • [40] Somatic hypermutation and VH gene usage in mantle cell lymphoma
    Thorsélius, M
    Walsh, S
    Eriksson, I
    Thunberg, U
    Johnson, A
    Backlin, C
    Enblad, G
    Sundström, C
    Roos, G
    Rosenquist, R
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2002, 68 (04) : 217 - 224